New cancer clinical trial: Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

Published on: April 09, 2019 at 07:00PM
Conditions:   Esophageal Cancer;   Non Small Cell Lung Cancer
Intervention:   Biological: Personalized mRNA Tumor Vaccine
Sponsors:   Stemirna Therapeutics;   The First Affiliated Hospital of Zhengzhou University
Not yet recruiting